Psy Therapeutics, Inc.

BOSTON, MA

OncologyFormed

What changed

$6.8M raise filed (Form D/A)

10mo agoRaise filed (Form D)Sep 12, 2025Source filing (opens the source filing in a new tab)

Momentum

49no change

Some recent activity, at a steady rate.

Runway (estimate)

~29months

The last disclosed raise still models out past a year.

Stage

Formed

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Filing
Form D/A · $6.8M
Sep 12, 2025
Psy Therapeutics, Inc. · private raise, self-reported by the issuer
SEC EDGAR · 0001410578-25-002156 (opens the source filing in a new tab)
Grant
R01 · $331k · non-dilutive
Jul 4, 2022
UNIVERSITY OF ROCHESTER · PI WELTE, MICHAEL ANDREAS · NICHD · award ends Mar 31, 2027 · Regulation and function of H2A.Z during the mid-blastula transition
NIH RePORTER · NIH RePORTER 11057607 (opens the source filing in a new tab)
Grant
R35 · $117k · non-dilutive
Jul 1, 2020
UNIVERSITY OF ROCHESTER · PI MURPHY, PATRICK J. · NIGMS · award ends Jun 30, 2025 · Function of Chromatin Features in Cellular Programming
NIH RePORTER · NIH RePORTER 11011631 (opens the source filing in a new tab)
Grant
R01 · $384k · non-dilutive
Apr 1, 2013
UNIVERSITY OF ROCHESTER · PI WELTE, MICHAEL ANDREAS · NIGMS · award ends Jun 30, 2026 · Lipid droplets as protein sequestration sites
NIH RePORTER · NIH RePORTER 11124233 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
new_entity links the filing record at 0.47{"reasons":["no candidate cleared the review threshold"]}

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

$6.8M raise filed (Form D/A)
10mo agoRaise filed (Form D)Source (opens the source filing in a new tab)
NIH R01 · $0.4M · Lipid droplets as protein sequestration sites
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R35 · $0.1M · Function of Chromatin Features in Cellular Programming
Apr 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.3M · Regulation and function of H2A.Z during the mid-blastula transition
Apr 2025Grant renewalSource (opens the source filing in a new tab)

Last disclosed raise

$6.8M

Filed Sep 12, 2025, self-reported by the issuer on a Form D and not audited by the SEC. The runway estimate counts down from this date at the modeled burn for a Formed company in oncology.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

Form D/A · $6.8M

R01 · $331k · non-dilutive

R35 · $117k · non-dilutive

R01 · $384k · non-dilutive